Infectious Disease Doctors in Galveston, TX Accepting Medicare

13 Infectious Disease doctors found. Showing 1 - 13

Dennis M Walling, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222    Fax: 409-772-0885

Norbert J Roberts Jr., MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222

Dr. David Reynoso, M.D., PH.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222

Dr. Miguel Mauricio Cabada Samame, MD MSC Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Boulevard Rt 0435, Galveston, TX 77555 Phone: 409-747-0223    Fax: 409-772-6527

Lucas Scott Blanton, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222

Melinda Barbara Tanabe, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1005 Harborside Dr 6th Floor, Galveston, TX 77555 Phone: 832-505-2450

Daniel Stanton, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2653

Joseph Patrik Hornak, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-7063    Fax: 409-747-8579

Alfred Lea, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222

Juan Carlos Sarria, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222

Miss Maria Alejandra Caravedo, M.D Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1005 Harborside Dr, Galveston, TX 77555 Phone: 409-772-0644    Fax: 305-585-8137

A. Clinton White Jr., MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-0234    Fax: 409-772-6527

Clovus Glen Mayhall, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222

News Archive

Obesity linked with longer hospital stays and higher costs in TKR patients

Obesity is associated with longer hospital stays and higher costs in total knee replacement (TKR) patients, independent of whether or not the patient has an obesity-related disease or condition (comorbidity), according to a new study published in the Journal of Bone and Joint Surgery (JBJS).

Johns Hopkins leads first 16-patient, multicenter "domino donor" kidney transplant

Surgical teams at The Johns Hopkins Hospital, Barnes-Jewish Hospital in St. Louis, INTEGRIS Baptist Medical Center in Oklahoma City and Henry Ford Hospital in Detroit successfully completed the first eight-way, multihospital, domino kidney transplant. The transplant involved eight donors - 3 men and 5 women along with eight organ recipients - 3 men and 5 women. "All Johns Hopkins patients are in good condition and are recovering as anticipated," according to Robert A. Montgomery, M.D., Ph.D., director of the Johns Hopkins Comprehensive Transplant Center.

Donors must continue funding R&D to bring new global health technologies to patients

In this post in the Hill's "Congress Blog," Kaitlin Christenson, the coalition director of the Global Health Technologies Coalition; Jim Connolly, president and CEO of Aeras; and Mel Spigelman, president and CEO of the TB Alliance, respond to a recently released G-FINDER report that shows "overall global investment in the research and development (R&D) of new global health technologies has declined for the first time since 2007, when the tracking of such funding began."

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.

DJO receives exclusive rights to sell Exos' range of upper extremity products

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that it has signed an exclusive distribution agreement with Exos Corporation, providing DJO with exclusive rights to sell Exos' broad range of upper extremity products that incorporate Exos' thermoformable polymer technology in North and South America.

Read more Medical News

› Verified 7 days ago